{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:15:21Z","timestamp":1772014521414,"version":"3.50.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005068","name":"Jimma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235365","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:46:58Z","timestamp":1593712018000},"page":"e0235365","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic"],"prefix":"10.1371","volume":"15","author":[{"given":"Assefa","family":"Kumsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyew","family":"Agenagnew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beza","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6946-4020","authenticated-orcid":true,"given":"Shimelis","family":"Girma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"pone.0235365.ref001","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1353-8020(13)70027-0","article-title":"Acute and subacute drug-induced movement disorders","volume":"20","author":"PR Burkhard","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"pone.0235365.ref002","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1517\/14740338.2015.1032244","article-title":"Drug-induced movement disorders","volume":"14","author":"Denes Zadori","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"2\u20133","key":"pone.0235365.ref003","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.psychres.2004.10.009","article-title":"Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or typical antipsychotics","volume":"133","author":"SA Strejilevich","year":"2005","journal-title":"Psychiatry Res"},{"issue":"2","key":"pone.0235365.ref004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.18773\/austprescr.2019.014","article-title":"Drug-induced movement disorders","volume":"42","author":"SR Duma","year":"2019","journal-title":"Aust Prescr"},{"issue":"8","key":"pone.0235365.ref005","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1212\/01.wnl.0000302255.49113.51","article-title":"Understanding drug-induced parkinsonism: separating pearls from oysters","volume":"70","author":"MVG Alvarez","year":"2008","journal-title":"Neurology"},{"key":"pone.0235365.ref006","first-page":"133","article-title":"Diagnostic and statistical manual of mental disorders","volume":"17","author":"AP Association","year":"2013","journal-title":"BMC Med"},{"key":"pone.0235365.ref007","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.161.1.160","article-title":"Prevalence of neurolepticinduced movement disorders in chronic schizophrenia inpatients","volume":"161","author":"S Janno","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"6","key":"pone.0235365.ref008","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/mds.20806","article-title":"Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambu\u00edstudy)","volume":"21","author":"MT Barbosa","year":"2006","journal-title":"Cardoso F Mov Disord"},{"issue":"1\u20132","key":"pone.0235365.ref009","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2011.02.015","article-title":"Prevalence of parkinsonism and Parkinson's disease in the Arosa Island (Spain): a community-based door-to-door survey","volume":"304","author":"M Seijo-Martinez","year":"2011","journal-title":"Sobrido MJ J Neurol Sci"},{"issue":"1","key":"pone.0235365.ref010","first-page":"7","volume":"16","author":"K Wo\u017aniak","year":"2016","journal-title":"Clinical assessment of antipsychotic-induced extrapyramidal symptoms in nursing home residents with schizophrenia"},{"key":"pone.0235365.ref011","first-page":"S1","article-title":"Spectrum of movement disorders at the premier Lagos Movement Disorders Clinic in Nigeria","volume":"27","author":"NU Okubadejo","year":"2012","journal-title":"Mov. Disord"},{"key":"pone.0235365.ref012","first-page":"36","article-title":"\u201cPrevalence and Pattern of Drug Induced Movement Disorders in University of Port Harcout Teaching Hospital(UPTH):A 3-year Review","volume":"1","author":"Princewill C Stanley","year":"2016","journal-title":"EC Neurol"},{"issue":"5","key":"pone.0235365.ref013","doi-asserted-by":"crossref","first-page":"76","DOI":"10.11648\/j.ajpn.20140205.12","article-title":"Antipsychotic medication induced movement disorders: The case of Amanuel Specialized Mental Hospital, Addis","volume":"2","author":"H Taye","year":"2014","journal-title":"American Journal of Psychiatry and Neuroscience"},{"issue":"Suppl 1","key":"pone.0235365.ref014","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00002826-198300061-00004","article-title":"Neuroleptic-induced extrapyramidal reactions: classification, d., and diagnosis","volume":"6","author":"D Tarsy","year":"1983","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"pone.0235365.ref015","first-page":"554","article-title":"Dopamine transporters decrease with age","volume":"37","author":"ND Volkow","year":"1996","journal-title":"Gur R J Nucl Med"},{"key":"pone.0235365.ref016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9343(99)80104-1","article-title":"Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study","volume":"99","author":"J Avorn","year":"1995","journal-title":"Am J Med"},{"issue":"1004","key":"pone.0235365.ref017","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/pgmj.2008.073312","article-title":"Drug induced Parkinsonism: a common cause of parkinsonism in older people","volume":"85","author":"B Thanvi","year":"2009","journal-title":"Postgrad Med J Jun"},{"issue":"Suppl 1","key":"pone.0235365.ref018","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/00002826-198300061-00007","article-title":"General principles of treatment of extrapyramidal syndromes","volume":"6","author":"AJ Gelenberg","year":"1983","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"pone.0235365.ref019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10488-006-0108-5","article-title":"Diamond. The Relationship of Antipsychotic Medication Class and Adherence with Treatment Outcomes and Costs for Florida Medicaid Beneficiaries with Schizophrenia","volume":"34","author":"A Marion","year":"2007","journal-title":"Administration and Policy in Mental Health and Mental Health Services Researchm"},{"key":"pone.0235365.ref020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hup.1143","article-title":"Relative association of treatment-emergent adverse events with quality of life of patients with schizophrenia: post hoc analysis from a 3-year observational study","volume":"25","author":"C Adrianz\u00e9n","year":"2010","journal-title":"Hum Psychopharmacol"},{"issue":"20","key":"pone.0235365.ref021","first-page":"498","article-title":"Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications:a systematic review and meta-analysis","volume":"157","author":"L Hartling","year":"2017","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0235365.ref022","first-page":"233","article-title":"The extrapyramidal symptom rating scale","volume":"7","author":"G. Chouinard","year":"1980","journal-title":"Can. J. Neurol. Sci"},{"key":"pone.0235365.ref023","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"M.M. Hoehn","year":"1967","journal-title":"Neurology"},{"key":"pone.0235365.ref024","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"W Guy","year":"1976"},{"key":"pone.0235365.ref025","article-title":"Alcohol, Smoking and Substance Involvement Screening Tool Version 3 .1: For health professionals Aust","author":"World Health Organization","year":"2010","journal-title":"Clinical Form"},{"issue":"19","key":"pone.0235365.ref026","first-page":"32","article-title":"Cop drug induced movement disorder us Rhann","volume":"11","author":"J Jack","year":"2007","journal-title":"Cop"},{"issue":"10","key":"pone.0235365.ref027","first-page":"1","volume":"6","author":"PR Bakker","year":"2011","journal-title":"Long-Stay Psychiatric Patients: A Prospective Study Revealing Persistent Antipsychotic-Induced Movement Disorder"},{"key":"pone.0235365.ref028","author":"SL Young","year":"2014","journal-title":"of the prevalence and management of antipsychotic adverse effects"},{"key":"pone.0235365.ref029","author":"S Janno","year":"2006","journal-title":"Assessment of neuroleptic-induced movement disorders in a naturalistic schizophrenia population"},{"key":"pone.0235365.ref030","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1176\/ajp.2006.163.8.1438","article-title":"Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study","volume":"163","author":"DE Tenback","year":"2006","journal-title":"Am J Psychiatry"},{"key":"pone.0235365.ref031","author":"T Thu","year":"2016","journal-title":"An original pharmaco-epidemiological pharmacodynamic method: application to antipsychotic-induced movement disorders"},{"issue":"5","key":"pone.0235365.ref032","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.mp.4002142","article-title":"Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions","volume":"13","author":"PR Bakker","year":"2008","journal-title":"Mol Psychiatry"},{"key":"pone.0235365.ref033","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Aging and Parkinson's disease: substantia nigra regional selectivity","volume":"l14","author":"JM Fearnley","year":"1991","journal-title":"Brain"},{"issue":"5","key":"pone.0235365.ref034","volume":"20","author":"RS Kirgaval","year":"2017","journal-title":"Prevalence of Extrapyramidal Side Effects in Patients on Antipsychotics Drugs at a Tertiary Care Center5"},{"issue":"November","key":"pone.0235365.ref035","first-page":"1521","article-title":"Prospective study of tardive dyskinesia in the Elderly: rates and risk factors","volume":"155","author":"A Jeffrey","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"10","key":"pone.0235365.ref036","first-page":"15","article-title":"D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET","volume":"60","author":"G. Remington","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"pone.0235365.ref037","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: a new hypothesis","volume":"158","author":"S. Kapur","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"pone.0235365.ref038","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","article-title":"Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs","volume":"200","author":"W Lewis","year":"2012","journal-title":"Br J Psychiatry"},{"key":"pone.0235365.ref039","doi-asserted-by":"crossref","first-page":"e100026","DOI":"10.1136\/gpsych-2018-100026","article-title":"Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia","volume":"32","author":"J Weng","year":"2019","journal-title":"General Psychiatry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:47:18Z","timestamp":1593712038000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235365"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"De Luca","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235365","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]}}}